-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines. ACTA, primarily drafted and secretly negotiated by the US, was signed on October...

Only 22 compensated in four years, admits drugs controller during RTI hearing As many as 2,031 people in India have died because of the clinical drug trials they were subjected to in the past four years. Only 22 of them have been compensated. What's more, no action has been taken so far against any Pharma company, ethics committee that oversees clinical trials or contract research organisation that conducts the trials, which...

The goal of universal health care requires an overhaul of the public health system, medical education and regulatory mechanisms. At long last, public health is on the agenda of the country’s policy makers. The Prime Minister’s Republic Day speech mentioned that the Twelfth Plan would focus on health just as the Eleventh Plan had focussed on education. But the manner in which the education sector has been messed with does not...

Regulations covering public health should override personal rights and the country cannot wait any more for a good public health law. The health care industry, including institutions of medical education, hospitals and pharmaceutical businesses, have grown into behemoths that can do considerable harm in the absence of independent and effective regulatory systems. While there are no success stories in the regulation of any kind of industry in India, I will focus...